1. Market Overview of Ophthalmology Disorders Drug
1.1 Ophthalmology Disorders Drug Market Overview
1.1.1 Ophthalmology Disorders Drug Product Scope
1.1.2 Market Status and Outlook
1.2 Ophthalmology Disorders Drug Market Size by Regions: 2015 VS 2021 VS 2026
1.3 Ophthalmology Disorders Drug Historic Market Size by Regions (2015-2020)
1.4 Ophthalmology Disorders Drug Forecasted Market Size by Regions (2021-2026)
1.5 Covid-19 Impact on Key Regions, Keyword Market Size YoY Growth (2015-2026)
1.5.1 North America
1.5.2 East Asia
1.5.3 Europe
1.5.4 South Asia
1.5.5 Southeast Asia
1.5.6 Middle East
1.5.7 Africa
1.5.8 Oceania
1.5.9 South America
1.5.10 Rest of the World
1.6 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.6.2 Covid-19 Impact: Commodity Prices Indices
1.6.3 Covid-19 Impact: Global Major Government Policy
2. Covid-19 Impact Ophthalmology Disorders Drug Sales Market by Type (2015-2026)
2.1 Global Ophthalmology Disorders Drug Historic Market Size by Type (2015-2020)
2.2 Global Ophthalmology Disorders Drug Forecasted Market Size by Type (2021-2026)
2.3 Oral
2.4 Injection
2.5 External Use
3. Covid-19 Impact Ophthalmology Disorders Drug Sales Market by Application (2015-2026)
3.1 Global Ophthalmology Disorders Drug Historic Market Size by Application (2015-2020)
3.2 Global Ophthalmology Disorders Drug Forecasted Market Size by Application (2021-2026)
3.3 Juvenile Macular Degeneration (Stargardt Disease)
3.4 Leber Congenital Amaurosis (LCA)
3.5 Lebers Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy)
3.6 Usher Syndrome
3.7 Retinitis Pigmentosa (Retinitis)
4. Covid-19 Impact Market Competition by Manufacturers
4.1 Global Ophthalmology Disorders Drug Production Capacity Market Share by Manufacturers (2015-2020)
4.2 Global Ophthalmology Disorders Drug Revenue Market Share by Manufacturers (2015-2020)
4.3 Global Ophthalmology Disorders Drug Average Price by Manufacturers (2015-2020)
5. Company Profiles and Key Figures in Ophthalmology Disorders Drug Business
5.1 Sanofi
5.1.1 Sanofi Company Profile
5.1.2 Sanofi Ophthalmology Disorders Drug Product Specification
5.1.3 Sanofi Ophthalmology Disorders Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.2 Bayer
5.2.1 Bayer Company Profile
5.2.2 Bayer Ophthalmology Disorders Drug Product Specification
5.2.3 Bayer Ophthalmology Disorders Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.3 Bausch + Lomb
5.3.1 Bausch + Lomb Company Profile
5.3.2 Bausch + Lomb Ophthalmology Disorders Drug Product Specification
5.3.3 Bausch + Lomb Ophthalmology Disorders Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.4 Novartis
5.4.1 Novartis Company Profile
5.4.2 Novartis Ophthalmology Disorders Drug Product Specification
5.4.3 Novartis Ophthalmology Disorders Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.5 Usher Syndrome
5.5.1 Usher Syndrome Company Profile
5.5.2 Usher Syndrome Ophthalmology Disorders Drug Product Specification
5.5.3 Usher Syndrome Ophthalmology Disorders Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.6 Takeda Pharmaceutical
5.6.1 Takeda Pharmaceutical Company Profile
5.6.2 Takeda Pharmaceutical Ophthalmology Disorders Drug Product Specification
5.6.3 Takeda Pharmaceutical Ophthalmology Disorders Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.7 Roche
5.7.1 Roche Company Profile
5.7.2 Roche Ophthalmology Disorders Drug Product Specification
5.7.3 Roche Ophthalmology Disorders Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.8 Pfizer
5.8.1 Pfizer Company Profile
5.8.2 Pfizer Ophthalmology Disorders Drug Product Specification
5.8.3 Pfizer Ophthalmology Disorders Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.9 Allergan
5.9.1 Allergan Company Profile
5.9.2 Allergan Ophthalmology Disorders Drug Product Specification
5.9.3 Allergan Ophthalmology Disorders Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.10 Gilead Sciences
5.10.1 Gilead Sciences Company Profile
5.10.2 Gilead Sciences Ophthalmology Disorders Drug Product Specification
5.10.3 Gilead Sciences Ophthalmology Disorders Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.11 Kubota Pharmaceutical
5.11.1 Kubota Pharmaceutical Company Profile
5.11.2 Kubota Pharmaceutical Ophthalmology Disorders Drug Product Specification
5.11.3 Kubota Pharmaceutical Ophthalmology Disorders Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.12 Alkeus Pharmaceuticals
5.12.1 Alkeus Pharmaceuticals Company Profile
5.12.2 Alkeus Pharmaceuticals Ophthalmology Disorders Drug Product Specification
5.12.3 Alkeus Pharmaceuticals Ophthalmology Disorders Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.13 Astellas Pharma
5.13.1 Astellas Pharma Company Profile
5.13.2 Astellas Pharma Ophthalmology Disorders Drug Product Specification
5.13.3 Astellas Pharma Ophthalmology Disorders Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.14 Ferrer Corporate
5.14.1 Ferrer Corporate Company Profile
5.14.2 Ferrer Corporate Ophthalmology Disorders Drug Product Specification
5.14.3 Ferrer Corporate Ophthalmology Disorders Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.15 Amgen Inc
5.15.1 Amgen Inc Company Profile
5.15.2 Amgen Inc Ophthalmology Disorders Drug Product Specification
5.15.3 Amgen Inc Ophthalmology Disorders Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.16 Editas Medicine Inc
5.16.1 Editas Medicine Inc Company Profile
5.16.2 Editas Medicine Inc Ophthalmology Disorders Drug Product Specification
5.16.3 Editas Medicine Inc Ophthalmology Disorders Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.17 ProQR Therapeutics NV
5.17.1 ProQR Therapeutics NV Company Profile
5.17.2 ProQR Therapeutics NV Ophthalmology Disorders Drug Product Specification
5.17.3 ProQR Therapeutics NV Ophthalmology Disorders Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.18 ReNeuron
5.18.1 ReNeuron Company Profile
5.18.2 ReNeuron Ophthalmology Disorders Drug Product Specification
5.18.3 ReNeuron Ophthalmology Disorders Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.19 Amarantus BioScience
5.19.1 Amarantus BioScience Company Profile
5.19.2 Amarantus BioScience Ophthalmology Disorders Drug Product Specification
5.19.3 Amarantus BioScience Ophthalmology Disorders Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.20 Ocugen
5.20.1 Ocugen Company Profile
5.20.2 Ocugen Ophthalmology Disorders Drug Product Specification
5.20.3 Ocugen Ophthalmology Disorders Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.21 ReGenX Biosciences
5.21.1 ReGenX Biosciences Company Profile
5.21.2 ReGenX Biosciences Ophthalmology Disorders Drug Product Specification
5.21.3 ReGenX Biosciences Ophthalmology Disorders Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.22 Sucampo Pharmaceuticals
5.22.1 Sucampo Pharmaceuticals Company Profile
5.22.2 Sucampo Pharmaceuticals Ophthalmology Disorders Drug Product Specification
5.22.3 Sucampo Pharmaceuticals Ophthalmology Disorders Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.23 Orphagen Pharmaceuticals
5.23.1 Orphagen Pharmaceuticals Company Profile
5.23.2 Orphagen Pharmaceuticals Ophthalmology Disorders Drug Product Specification
5.23.3 Orphagen Pharmaceuticals Ophthalmology Disorders Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.24 Okuvision
5.24.1 Okuvision Company Profile
5.24.2 Okuvision Ophthalmology Disorders Drug Product Specification
5.24.3 Okuvision Ophthalmology Disorders Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.25 Second Sight Medical
5.25.1 Second Sight Medical Company Profile
5.25.2 Second Sight Medical Ophthalmology Disorders Drug Product Specification
5.25.3 Second Sight Medical Ophthalmology Disorders Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.26 Acucela
5.26.1 Acucela Company Profile
5.26.2 Acucela Ophthalmology Disorders Drug Product Specification
5.26.3 Acucela Ophthalmology Disorders Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.27 Stealth BioTherapeutics
5.27.1 Stealth BioTherapeutics Company Profile
5.27.2 Stealth BioTherapeutics Ophthalmology Disorders Drug Product Specification
5.27.3 Stealth BioTherapeutics Ophthalmology Disorders Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.28 Sun Pharma Advanced Research Company
5.28.1 Sun Pharma Advanced Research Company Company Profile
5.28.2 Sun Pharma Advanced Research Company Ophthalmology Disorders Drug Product Specification
5.28.3 Sun Pharma Advanced Research Company Ophthalmology Disorders Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.29 AmpliPhi Biosciences
5.29.1 AmpliPhi Biosciences Company Profile
5.29.2 AmpliPhi Biosciences Ophthalmology Disorders Drug Product Specification
5.29.3 AmpliPhi Biosciences Ophthalmology Disorders Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.30 Applied Genetic Technologies
5.30.1 Applied Genetic Technologies Company Profile
5.30.2 Applied Genetic Technologies Ophthalmology Disorders Drug Product Specification
5.30.3 Applied Genetic Technologies Ophthalmology Disorders Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.31 Asklepios BioPharmaceutical
5.31.1 Asklepios BioPharmaceutical Company Profile
5.31.2 Asklepios BioPharmaceutical Ophthalmology Disorders Drug Product Specification
5.31.3 Asklepios BioPharmaceutical Ophthalmology Disorders Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.32 Biovista
5.32.1 Biovista Company Profile
5.32.2 Biovista Ophthalmology Disorders Drug Product Specification
5.32.3 Biovista Ophthalmology Disorders Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.33 Spark Therapeutics
5.33.1 Spark Therapeutics Company Profile
5.33.2 Spark Therapeutics Ophthalmology Disorders Drug Product Specification
5.33.3 Spark Therapeutics Ophthalmology Disorders Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.34 Caladrius Biosciences
5.34.1 Caladrius Biosciences Company Profile
5.34.2 Caladrius Biosciences Ophthalmology Disorders Drug Product Specification
5.34.3 Caladrius Biosciences Ophthalmology Disorders Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.35 Dompe Farmaceutici
5.35.1 Dompe Farmaceutici Company Profile
5.35.2 Dompe Farmaceutici Ophthalmology Disorders Drug Product Specification
5.35.3 Dompe Farmaceutici Ophthalmology Disorders Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.36 Dormant Projects
5.36.1 Dormant Projects Company Profile
5.36.2 Dormant Projects Ophthalmology Disorders Drug Product Specification
5.36.3 Dormant Projects Ophthalmology Disorders Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.37 Grupo Ferrer Internacional
5.37.1 Grupo Ferrer Internacional Company Profile
5.37.2 Grupo Ferrer Internacional Ophthalmology Disorders Drug Product Specification
5.37.3 Grupo Ferrer Internacional Ophthalmology Disorders Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.38 ID Pharma
5.38.1 ID Pharma Company Profile
5.38.2 ID Pharma Ophthalmology Disorders Drug Product Specification
5.38.3 ID Pharma Ophthalmology Disorders Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.39 InFlectis BioScience
5.39.1 InFlectis BioScience Company Profile
5.39.2 InFlectis BioScience Ophthalmology Disorders Drug Product Specification
5.39.3 InFlectis BioScience Ophthalmology Disorders Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.40 Ionis Pharmaceuticals
5.40.1 Ionis Pharmaceuticals Company Profile
5.40.2 Ionis Pharmaceuticals Ophthalmology Disorders Drug Product Specification
5.40.3 Ionis Pharmaceuticals Ophthalmology Disorders Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.41 Ixchel Pharma
5.41.1 Ixchel Pharma Company Profile
5.41.2 Ixchel Pharma Ophthalmology Disorders Drug Product Specification
5.41.3 Ixchel Pharma Ophthalmology Disorders Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.42 Khondrion
5.42.1 Khondrion Company Profile
5.42.2 Khondrion Ophthalmology Disorders Drug Product Specification
5.42.3 Khondrion Ophthalmology Disorders Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.43 Mimetogen Pharmaceuticals
5.43.1 Mimetogen Pharmaceuticals Company Profile
5.43.2 Mimetogen Pharmaceuticals Ophthalmology Disorders Drug Product Specification
5.43.3 Mimetogen Pharmaceuticals Ophthalmology Disorders Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.44 Mitotech
5.44.1 Mitotech Company Profile
5.44.2 Mitotech Ophthalmology Disorders Drug Product Specification
5.44.3 Mitotech Ophthalmology Disorders Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.45 M's Science
5.45.1 M's Science Company Profile
5.45.2 M's Science Ophthalmology Disorders Drug Product Specification
5.45.3 M's Science Ophthalmology Disorders Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.46 Nanovector
5.46.1 Nanovector Company Profile
5.46.2 Nanovector Ophthalmology Disorders Drug Product Specification
5.46.3 Nanovector Ophthalmology Disorders Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.47 SanBio
5.47.1 SanBio Company Profile
5.47.2 SanBio Ophthalmology Disorders Drug Product Specification
5.47.3 SanBio Ophthalmology Disorders Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
6. North America
6.1 North America Ophthalmology Disorders Drug Market Size (2015-2026)
6.2 North America Ophthalmology Disorders Drug Key Players in North America (2015-2020)
6.3 North America Ophthalmology Disorders Drug Market Size by Type (2015-2020)
6.4 North America Ophthalmology Disorders Drug Market Size by Application (2015-2020)
7. East Asia
7.1 East Asia Ophthalmology Disorders Drug Market Size (2015-2026)
7.2 East Asia Ophthalmology Disorders Drug Key Players in North America (2015-2020)
7.3 East Asia Ophthalmology Disorders Drug Market Size by Type (2015-2020)
7.4 East Asia Ophthalmology Disorders Drug Market Size by Application (2015-2020)
8. Europe
8.1 Europe Ophthalmology Disorders Drug Market Size (2015-2026)
8.2 Europe Ophthalmology Disorders Drug Key Players in North America (2015-2020)
8.3 Europe Ophthalmology Disorders Drug Market Size by Type (2015-2020)
8.4 Europe Ophthalmology Disorders Drug Market Size by Application (2015-2020)
9. South Asia
9.1 South Asia Ophthalmology Disorders Drug Market Size (2015-2026)
9.2 South Asia Ophthalmology Disorders Drug Key Players in North America (2015-2020)
9.3 South Asia Ophthalmology Disorders Drug Market Size by Type (2015-2020)
9.4 South Asia Ophthalmology Disorders Drug Market Size by Application (2015-2020)
10. Southeast Asia
10.1 Southeast Asia Ophthalmology Disorders Drug Market Size (2015-2026)
10.2 Southeast Asia Ophthalmology Disorders Drug Key Players in North America (2015-2020)
10.3 Southeast Asia Ophthalmology Disorders Drug Market Size by Type (2015-2020)
10.4 Southeast Asia Ophthalmology Disorders Drug Market Size by Application (2015-2020)
11. Middle East
11.1 Middle East Ophthalmology Disorders Drug Market Size (2015-2026)
11.2 Middle East Ophthalmology Disorders Drug Key Players in North America (2015-2020)
11.3 Middle East Ophthalmology Disorders Drug Market Size by Type (2015-2020)
11.4 Middle East Ophthalmology Disorders Drug Market Size by Application (2015-2020)
12. Africa
12.1 Africa Ophthalmology Disorders Drug Market Size (2015-2026)
12.2 Africa Ophthalmology Disorders Drug Key Players in North America (2015-2020)
12.3 Africa Ophthalmology Disorders Drug Market Size by Type (2015-2020)
12.4 Africa Ophthalmology Disorders Drug Market Size by Application (2015-2020)
13. Oceania
13.1 Oceania Ophthalmology Disorders Drug Market Size (2015-2026)
13.2 Oceania Ophthalmology Disorders Drug Key Players in North America (2015-2020)
13.3 Oceania Ophthalmology Disorders Drug Market Size by Type (2015-2020)
13.4 Oceania Ophthalmology Disorders Drug Market Size by Application (2015-2020)
14. South America
14.1 South America Ophthalmology Disorders Drug Market Size (2015-2026)
14.2 South America Ophthalmology Disorders Drug Key Players in North America (2015-2020)
14.3 South America Ophthalmology Disorders Drug Market Size by Type (2015-2020)
14.4 South America Ophthalmology Disorders Drug Market Size by Application (2015-2020)
15. Rest of the World
15.1 Rest of the World Ophthalmology Disorders Drug Market Size (2015-2026)
15.2 Rest of the World Ophthalmology Disorders Drug Key Players in North America (2015-2020)
15.3 Rest of the World Ophthalmology Disorders Drug Market Size by Type (2015-2020)
15.4 Rest of the World Ophthalmology Disorders Drug Market Size by Application (2015-2020)
16 Ophthalmology Disorders Drug Market Dynamics
16.1 Covid-19 Impact Market Top Trends
16.2 Covid-19 Impact Market Drivers
16.3 Covid-19 Impact Market Challenges
16.4 Porters Five Forces Analysis
18 Regulatory Information
17 Analyst's Viewpoints/Conclusions
18 Appendix
18.1 Research Methodology
18.1.1 Methodology/Research Approach
18.1.2 Data Source
18.2 Disclaimer

Menu 2

Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam.